394 results on '"Tang, Chao-Ke"'
Search Results
2. Apelin-13: A Protective Role in Vascular Diseases
3. History and Development of ABCA1
4. Role and therapeutic potential of gelsolin in atherosclerosis
5. ABCA1, ABCG1, and Cholesterol Homeostasis
6. Sterol carrier protein 2 in lipid metabolism and non-alcoholic fatty liver disease: Pathophysiology, molecular biology, and potential clinical implications
7. ABCA1, ABCG1, and Cholesterol Homeostasis
8. TIGAR mitigates atherosclerosis by promoting cholesterol efflux from macrophages
9. Resistin: Potential biomarker and therapeutic target in atherosclerosis
10. Krüppel-like factor 14 inhibits atherosclerosis via mir-27a-mediated down-regulation of lipoprotein lipase expression in vivo
11. CXC chemokine ligand 12 (CXCL12) in atherosclerosis: An underlying therapeutic target
12. Coiled-coil domain-containing 80 accelerates atherosclerosis development through decreasing lipoprotein lipase expression via ERK1/2 phosphorylation and TET2 expression
13. Pregnancy-associated plasma protein-A in atherosclerosis: Molecular marker, mechanistic insight, and therapeutic target
14. Apelin-13: a protective role in vascular diseases
15. Protein tyrosine phosphatase non-receptor type 2 as the therapeutic target of atherosclerotic diseases: past, present and future
16. History and development of ABCA1
17. Astragalin retards atherosclerosis by promoting cholesterol efflux and inhibiting the inflammatory response via up-regulating ABCA1 and ABCG1 expression in macrophages
18. C1q tumor necrosis factor-related protein 9 in atherosclerosis: Mechanistic insights and therapeutic potential
19. AIBP reduces atherosclerosis by promoting reverse cholesterol transport and ameliorating inflammation in apoE−/− mice
20. Retraction notice to “Betulinic acid downregulates expression of oxidative stress-induced lipoprotein lipase via PKC/ERK/c-Fos pathways in RAW264.7 macrophages” [Biochimie 119C (2015) 192–203]
21. CTRP1: A novel player in cardiovascular and metabolic diseases
22. The role of Krüppel-like factor 14 in the pathogenesis of atherosclerosis
23. Myocardin: A novel player in atherosclerosis
24. Sterol carrier protein 2: A promising target in the pathogenesis of atherosclerosis
25. MicroRNA-186 promotes macrophage lipid accumulation and secretion of pro-inflammatory cytokines by targeting cystathionine γ-lyase in THP-1 macrophages
26. Apolipoprotein A-1 binding protein promotes macrophage cholesterol efflux by facilitating apolipoprotein A-1 binding to ABCA1 and preventing ABCA1 degradation
27. PVT1 in cardiovascular disease: A promising therapeutic target
28. The authors' reply to the letter “CA125 a cause or an effect in heart failure?”
29. ApoA-1 Mimetic Peptide ELK-2A2K2E Decreases Inflammatory Factor Levels Through the ABCA1-JAK2-STAT3-TTP Axis in THP-1–Derived Macrophages
30. Targeting CA125 in cardiovascular disease
31. HAND2-AS1: A novel therapeutic target for atherosclerosis
32. Hsp27 promotes ABCA1 expression and cholesterol efflux through the PI3K/PKCζ/Sp1 pathway in THP-1 macrophages
33. CORRIGENDUM: MicroRNA-182 Promotes Lipoprotein Lipase Expression and Atherogenesisby Targeting Histone Deacetylase 9 in Apolipoprotein E-Knockout Mice
34. Corrigendum to “IL-8 negatively regulates ABCA1 expression and cholesterol efflux via upregulating miR-183 in THP-1 macrophage-derived foam cells” [Cytokine 122 (2019) 154385]
35. Corrigendum to “Apelin-13 impedes foam cells formation by activating ClassIIIPI3K/Beclin mediated autophagic pathway”
36. Peroxisome Proliferator-Activated Receptor α in Lipid Metabolism and Atherosclerosis
37. Nuclear Factor-κB Activation as a Pathological Mechanism of Lipid Metabolism and Atherosclerosis
38. Microtubule affinity regulating kinase 4: A promising target in the pathogenesis of atherosclerosis
39. Hepatic cholesterol transport and its role in non-alcoholic fatty liver disease and atherosclerosis
40. Long non-coding RNA PCA3 inhibits lipid accumulation and atherosclerosis through the miR-140-5p/RFX7/ABCA1 axis
41. Myocardin suppression increases lipid retention and atherosclerosis via downregulation of ABCA1 in vascular smooth muscle cells
42. The Interaction of ApoA-I and ABCA1 Triggers Signal Transduction Pathways to Mediate Efflux of Cellular Lipids
43. ATP-Binding Membrane Cassette Transporter A1 (ABCA1): A Possible Link between Inflammation and Reverse Cholesterol Transport
44. NO-1886 Up-regulates Niemann–Pick C1 Protein (NPC1) Expression Through Liver X Receptor α Signaling Pathway in THP-1 Macrophage-Derived Foam Cells
45. Astragalin Retards Atherosclerosis by Promoting Cholesterol Efflux and Inhibiting the Inflammatory Response via Upregulating ABCA1 and ABCG1 Expression in Macrophages
46. Zinc finger E‐box binding homeobox 1 and atherosclerosis: New insights and therapeutic potential
47. Artesunate inhibits atherosclerosis by upregulating vascular smooth muscle cells-derived LPL expression via the KLF2/NRF2/TCF7L2 pathway
48. Microtubule affinity regulating kinase 4: A promising target in the pathogenesis of atherosclerosis.
49. Fargesin alleviates atherosclerosis by promoting reverse cholesterol transport and reducing inflammatory response
50. Coronavirus disease 2019 (COVID-19): current status and future perspectives
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.